ADIM
MNDT

Alpha DNA Investment Management’s Mandiant, Inc. Common Stock MNDT Stock Holding History

Alpha DNA Investment Management’s Portfolio MNDT Stock Details MNDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-68,291
Closed -$1.38M – 152
2021
Q2 		$1.38M Buy
68,291
+67,996
+23,049% +$1.39M 0.94% 73
2021
Q1 		$5K Buy
295
+154
+109% +$3.22K 0.01% 389
2020
Q4 		$3K Buy
+141
New +$2.17K ﹤0.01% 437

Other funds holding MNDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Alpha DNA Investment Management's MNDT Position: Q3 2021 in Review

Alpha DNA Investment Management sold out of Mandiant, Inc. Common Stock (MNDT) in Q3 2021, closing a stake of 68,291 shares — an estimated $1.38M sold.

Alpha DNA Investment Management first reported a position in MNDT in Q4 2020 and held it in 3 quarters. The position peaked at $1.38M in Q2 2021. 274 funds tracked by Wall St. Rank hold MNDT as of Q3 2021.

  • Alpha DNA Investment Management reported no remaining Mandiant, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 68,291 Mandiant, Inc. Common Stock shares in Q3 2021, an estimated $1.38M.
  • Alpha DNA Investment Management first reported a position in Mandiant, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Mandiant, Inc. Common Stock position peaked at $1.38M in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q3 2021.

Based on Alpha DNA Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.